Novel chitosan-polydopamine hydrogel exhibits high strength and antibacterial properties, suggesting new biomedical applications.
Herein, a novel chitosan-polydopamine hydrogel was constructed through the in situ self-polymerization of dopamine in a chitosan/alkali aqueous solution. Solid-state 13C NMR, FTIR, and SEM confirmed that the formed polydopamine (PDA) particles easily wrapped on chitosan chains to fabricate homogeneous porous hydrogels with pearl-like PDA-chitosan nanofibrils. Thus, the hybrid hydrogels exhibited homogeneous architecture with a high compressive strength of 0.43 MPa. At elevated dopamine (DA) content, the size of PDA particles gradually enlarged from 14 to 32 nm, and a denser network structure was formed because chitosan and DA were partially crosslinked by epichlorohydrin (ECH). Furthermore, PDA endowed the hybrid hydrogels with excellent drug-loading capacity, radical scavenging, and antibacterial activities, which displayed great potential for biomedical and therapeutic applications. Therefore, we provide a new avenue for the creation of polymeric hybrid biomaterials from an alkali aqueous solution.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: